Your browser doesn't support javascript.
loading
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Mendel, Arielle; Bernatsky, Sasha B; Hanly, John G; Urowitz, Murray B; Clarke, Ann Elaine; Romero-Diaz, Juanita; Gordon, Caroline; Bae, Sang-Cheol; Wallace, Daniel J; Merrill, Joan T; Buyon, Jill P; Isenberg, David A; Rahman, Anisur; Ginzler, Ellen M; Petri, Michelle; Dooley, Mary Anne; Fortin, Paul R; Gladman, Dafna D; Steinsson, Kristján; Ramsey-Goldman, Rosalind; Khamashta, Munther A; Aranow, Cynthia; Mackay, Meggan; Alarcón, Graciela S; Manzi, Susan; Nived, Ola; Jönsen, Andreas; Zoma, Asad A; van Vollenhoven, Ronald F; Ramos-Casals, Manuel; Ruiz-Irastorza, Guillermo; Lim, Sam; Kalunian, Ken C; Inanc, Murat; Kamen, Diane L; Peschken, Christine A; Jacobsen, Søren; Askanase, Anca; Sanchez-Guerrero, Jorge; Bruce, Ian N; Costedoat-Chalumeau, Nathalie; Vinet, Évelyne.
Afiliação
  • Mendel A; Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Bernatsky SB; Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.
  • Hanly JG; Division of Clinical Epidemiology, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
  • Urowitz MB; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Clarke AE; Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Romero-Diaz J; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Gordon C; Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición, Tlalpan, Mexico.
  • Bae SC; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Wallace DJ; Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
  • Merrill JT; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
  • Buyon JP; Cedars-Sinai Medical Centre, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Isenberg DA; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Rahman A; Division of Rheumatology, Department of Medicine, New York School of Medicine, New York City, New York, USA.
  • Ginzler EM; Department of Medicine, Centre for Rheumatology, University College London, London, UK.
  • Petri M; Department of Medicine, Centre for Rheumatology, University College London, London, UK.
  • Dooley MA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA.
  • Fortin PR; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gladman DD; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Steinsson K; Division of Rheumatology, Centre Hospitalier Universitaire de Québec et Université Laval, Québec City, Quebec, Canada.
  • Ramsey-Goldman R; Lupus Program, Centre for Prognosis Studies in the Rheumatic Disease and Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Khamashta MA; Center for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland.
  • Aranow C; Division of Rheumatology, Feinberg School of Medicine, Northwestern University Chicago, Chicago, Illinois, USA.
  • Mackay M; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, London, UK.
  • Alarcón GS; Lupus Center of Excellence, Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • Manzi S; Lupus Center of Excellence, Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • Nived O; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Jönsen A; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Zoma AA; Department of Clinical Sciences and Rheumatology, Lund University, Lund, Sweden.
  • van Vollenhoven RF; Department of Clinical Sciences and Rheumatology, Lund University, Lund, Sweden.
  • Ramos-Casals M; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK.
  • Ruiz-Irastorza G; Unit for Clinical Therapy Research (CliTRID), Karolinska Institute, Stockholm, Sweden.
  • Lim S; Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain.
  • Kalunian KC; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
  • Inanc M; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Kamen DL; University of California San Diego School of Medicine, La Jolla, California, USA.
  • Peschken CA; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
  • Jacobsen S; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Askanase A; Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Sanchez-Guerrero J; Copenhagen Lupus and Vasculitis Clinic, Section 4242, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bruce IN; Hospital for Joint Diseases, Seligman Centre for Advanced Therapeutics, New York University, New York City, New York, USA.
  • Costedoat-Chalumeau N; Department of Rheumatology, Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Vinet É; NIHR Manchester Biomedical Research Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Ann Rheum Dis ; 78(7): 1010-1012, 2019 07.
Article em En | MEDLINE | ID: mdl-30573656
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Complicações na Gravidez / Inibidores da Agregação Plaquetária / Aspirina / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Complicações na Gravidez / Inibidores da Agregação Plaquetária / Aspirina / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá